SALARIUS PHARMACEUTICALS, INC. FLKS Balance Sheet

Salarius pharmaceuticals, inc. (FLKS)

Balance Sheet / Yearly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14
Assets
Current assets:
Cash and cash equivalents
9,646	3,738	3,999	6,514	7,297	3,228	-	-	-	19,186	-	-	-	-	-	-	-	-	-	-	-	-
Grants receivable from CPRIT
591	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Restricted cash
-	-	0	0	0	2,903	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Cash and cash equivalents
-	-	-	-	-	-	12,961	15,756	21,948	-	20,152	39,126	21,071	22,416	27,829	38,941	53,999	66,686	89,159	106,011	110,522	33,854
Marketable securities
-	-	-	-	-	-	0	0	1,999	14,129	18,776	7,996	31,743	38,658	39,504	35,912	30,377	24,652	9,999	-	-	0
Accounts receivable
-	-	-	28	9	-	20	17	12	10	35	34	19	12	21	11	-	0	-	-	-	-
Inventory
-	-	-	130	164	-	223	275	418	431	533	688	414	454	230	274	112	0	-	-	-	-
Prepaid expenses and other current assets
646	955	1,239	435	675	249	478	856	1,261	777	1,056	1,209	1,585	925	1,554	2,259	1,992	908	1,085	810	1,054	370
Total current assets
10,884	4,694	5,239	7,109	8,146	6,380	13,684	16,906	25,639	34,535	40,553	49,055	54,833	62,467	69,140	77,399	86,481	92,247	100,244	106,821	111,577	34,224
Marketable securities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	2,312	-	-	-	0
Property and equipment, net
21	25	28	27	38	37	127	180	266	331	400	448	479	556	619	637	578	382	255	118	104	85
Goodwill
8,865	8,865	8,865	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Restricted cash
-	-	-	-	-	-	126	126	126	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred IPO issuance costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	1,074
Deferred tax assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	50	50	50	50
Other assets
293	308	324	-	-	195	-	-	-	-	0	0	64	64	64	64	64	0	85	85	85	50
Restricted cash
-	-	-	-	-	-	-	-	-	126	253	126	126	126	126	126	126	126	126	126	126	126
Total assets
20,065	13,894	14,457	7,137	8,184	6,613	13,938	17,212	26,033	34,992	41,208	49,629	55,504	63,214	69,951	78,228	87,251	95,069	100,762	107,202	111,943	35,611
Liabilities and stockholders' equity (deficit)
Current liabilities:
Accounts payable
979	1,790	1,643	805	186	379	1,279	1,145	2,241	2,004	919	1,806	818	1,192	1,256	1,544	1,541	875	692	812	567	578
Accrued expenses and other current liabilities
795	160	245	230	724	628	1,554	2,588	1,820	3,712	3,897	3,130	2,311	2,587	2,549	1,761	1,478	1,947	1,559	1,229	777	416
Due to related parties
-	-	4	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Private Salarius accrued series A preferred units
-	-	0	-	-	2,869	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Note payable
252	502	749	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred revenue
0	541	1,580	-	-	4,006	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Warrant liability
34	317	498	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred revenue
-	-	-	-	-	-	-	-	0	72	97	96	80	88	81	65	-	0	-	-	-	-
Deferred tax liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	50	50	50	50
Deferred rent, current portion
-	-	-	-	-	-	53	58	58	58	58	0	7	21	25	25	24	24	21	21	21	21
Total current liabilities
-	-	-	1,036	911	-	2,887	3,792	4,120	5,847	4,972	5,033	3,218	3,889	3,913	3,397	3,044	2,847	2,324	2,113	1,417	1,067
Deferred rent, net of current portion
-	-	-	-	-	-	0	9	24	39	53	91	59	8	10	15	22	14	22	27	29	35
Other long term liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	15	15	415	415	415	15
Total liabilities
2,062	3,313	4,720	1,036	911	7,884	2,887	3,802	4,145	5,886	5,026	5,125	3,277	3,897	3,923	3,412	3,082	2,877	2,762	2,556	1,862	1,118
Commitments and Contingencies
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Stockholders' equity (deficit):
Preferred stock, $0.0001 par value; 10,000,000 shares authorized; 468,694 issued and outstanding
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Common stock, $0.0001 par value; 100,000,000 shares authorized; 13,650,838 and 4,519,533 shares issued at March 31, 2020 and December 31, 2019, and 13,645,677 and 4,511,174 shares outstanding at March 31, 2020 and December 31, 2019, respectively
1	0	3	1	1	0	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	0
Additional paid-in capital
32,161	22,657	19,927	142,675	142,463	3,869	142,000	141,722	141,148	140,184	139,231	138,227	137,151	135,962	134,757	132,882	130,893	129,367	127,261	125,751	124,108	1,472
Accumulated other comprehensive loss
-	-	-	-	-	-	0	0	0	-1	-1	-5	-12	-1	14	39	19	-24	-3	-	-	0
Accumulated deficit
-14,160	-12,076	-10,193	-136,576	-135,191	-5,140	-130,952	-128,314	-119,262	-111,079	-103,050	-93,718	-84,914	-76,645	-68,745	-58,108	-46,744	-37,152	-29,259	-21,106	-14,028	-8,010
Total stockholders' equity
18,002	10,580	9,737	6,101	7,273	-1,271	11,050	13,410	21,888	29,105	36,181	44,504	52,227	59,317	66,027	74,815	84,169	92,192	97,999	104,646	110,081	-6,538
Total liabilities and stockholders' equity
20,065	13,894	14,457	7,137	8,184	6,613	13,938	17,212	26,033	34,992	41,208	49,629	55,504	63,214	69,951	78,228	87,251	95,069	100,762	107,202	111,943	35,611